Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing SARS-CoV-2 (COVID-19) Seroprevalence During Routine Antenatal Care Visits in Zambia

NCT07021807 is registered in ClinicalTrials.gov with Centre for Infectious Disease Research in Zambia as lead sponsor.

NCT NCT07021807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07021807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing SARS-CoV-2 (COVID-19) Seroprevalence During Routine Antenatal Care Visits in Zambia
Lead sponsor
Centre for Infectious Disease Research in Zambia
Phase
Observational
Overall status
Completed
Start date
September 6, 2021
Completion date
March 30, 2023
Enrollment
9,111 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 seroprevalence